We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+4.44%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$28.3B
AUM Growth
+$2.33B
(+9%)
Cap. Flow
+$1.79B
Cap. Flow
% of AUM
6.32%
Top 10 Holdings %
Top 10 Hldgs %
25.96%
Holding
1,069
New
128
Increased
377
Reduced
389
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$356M |
| 2 |
Lam Research
LRCX
|
+$283M |
| 3 |
Palo Alto Networks
PANW
|
+$261M |
| 4 |
GE Vernova
GEV
|
+$216M |
| 5 |
Tractor Supply
TSCO
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$275M |
| 2 |
Intuit
INTU
|
+$214M |
| 3 |
CrowdStrike
CRWD
|
+$204M |
| 4 |
Williams-Sonoma
WSM
|
+$164M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$150M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.61% |
| 2 | Financials | 14.28% |
| 3 | Consumer Discretionary | 13.77% |
| 4 | Industrials | 12.88% |
| 5 | Healthcare | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Coherus Oncology
CHRS
$222M
| – | – |
-252,330
| Closed | -$262K |
|
952
Centene
CNC
$31.6B
| – | – |
-144,696
| Closed | -$10.9M |
|
953
Coursera
COUR
$1.68B
| – | – |
-1,365,520
| Closed | -$10.8M |
|
954
California Resources
CRC
$4.38B
| – | – |
-69,267
| Closed | -$3.63M |
|
955
Cerence
CRNC
$368M
| – | – |
-823,428
| Closed | -$2.59M |
|
956
Corsair Gaming
CRSR
$1.15B
| – | – |
-157,228
| Closed | -$1.09M |
|
957
Cytek Biosciences
CTKB
$576M
| – | – |
-182,713
| Closed | -$1.01M |
|
958
Customers Bancorp
CUBI
$2.69B
| – | – |
-249,588
| Closed | -$11.6M |
|
959
CVS Health
CVS
$140B
| – | – |
-115,032
| Closed | -$7.23M |
|
960
DigitalBridge
DBRG
$2.93B
| – | – |
-83,362
| Closed | -$1.18M |
|
961
Ginkgo Bioworks
DNA
$503M
| – | – |
-279,954
| Closed | -$2.28M |
|
|
DOCU
962
DocuSign
DOCU
$10.7B
| – | – |
-423,612
| Closed | -$26.3M |
|
963
Dynatrace
DT
$12.7B
| – | – |
-71,431
| Closed | -$3.82M |
|
964
Devon Energy
DVN
$49.2B
| – | – |
-14,798
| Closed | -$579K |
|
965
Ecovyst
ECVT
$1.35B
| – | – |
-372,049
| Closed | -$2.55M |
|
966
Consolidated Edison
ED
$41.3B
| – | – |
-8,372
| Closed | -$872K |
|
967
Euronet Worldwide
EEFT
$3.15B
| – | – |
-16,348
| Closed | -$1.62M |
|
968
eGain
EGAN
$190M
| – | – |
-20,917
| Closed | -$107K |
|
969
Edison International
EIX
$30.7B
| – | – |
-16,668
| Closed | -$1.45M |
|
970
Estee Lauder
EL
$30.7B
| – | – |
-61,927
| Closed | -$6.17M |
|
971
Equity Lifestyle Properties
ELS
$12.8B
| – | – |
-7,832
| Closed | -$559K |
|
|
ETNB
972
DELISTED
89bio
ETNB
| – | – |
-130,894
| Closed | -$969K |
|
973
Expensify
EXFY
$173M
| – | – |
-76,945
| Closed | -$151K |
|
974
Ezcorp Inc
EZPW
$1.85B
| – | – |
-145,008
| Closed | -$1.63M |
|
|
KYNB
975
Kyntra Bio
KYNB
$28.2M
| – | – |
-84,342
| Closed | -$842K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2024 Portfolio in Review
As of Q4 2024, Jacobs Levy Equity Management held 1,069 positions worth $28.3B, up 9% from $25.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jacobs Levy Equity Management deployed $1.79B of net new capital in Q4 2024, opening 128 new positions and adding to 377 existing holdings. Its largest new stake was Tractor Supply: 2,947,687 shares worth $156M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Amphenol, an estimated $275M trimmed.
- Jacobs Levy Equity Management's largest Q4 2024 buy was Tractor Supply: 2,947,687 shares worth $156M.
- Jacobs Levy Equity Management added most to Arista Networks in Q4 2024, an estimated $356M increase.
- Jacobs Levy Equity Management's biggest Q4 2024 reduction was Amphenol, cutting an estimated $275M.
- Jacobs Levy Equity Management fully exited Sarepta Therapeutics in Q4 2024, selling an estimated $94.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 26% of its $28.3B portfolio in Q4 2024.
- Jacobs Levy Equity Management opened 128 new positions and closed 143 in Q4 2024.
- Jacobs Levy Equity Management's portfolio value rose 9% quarter-over-quarter to $28.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2024, filed 14 Feb 2025.